Stage II Colon Cancer
Information
- Disease name
- Stage II Colon Cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04164069 | Active, not recruiting | Phase 1 | Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab | September 2, 2020 | December 31, 2023 |
| NCT02250053 | Completed | N/A | Exercise and Colon Cancer | December 2015 | January 15, 2016 |
| NCT00004931 | Completed | Phase 3 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | February 2000 | |
| NCT00433576 | Completed | Phase 1 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | December 2006 | March 2009 |
| NCT02129218 | Completed | N/A | Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer | February 16, 2015 | July 10, 2018 |
| NCT05870800 | Not yet recruiting | Phase 2 | Neoadjuvant Chemoimmunotherapy for Resectable Non-Metastatic Proficient Mismatch Repair (PMMR) Colon Cancer | September 1, 2024 | January 1, 2028 |
| NCT04303429 | Not yet recruiting | Phase 3 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | August 2020 | January 2025 |
| NCT05062889 | Recruiting | Phase 2 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | May 17, 2023 | December 2027 |
| NCT04416490 | Recruiting | Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer | March 25, 2020 | March 31, 2026 | |
| NCT00087191 | Terminated | N/A | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | May 2004 | |
| NCT01606124 | Terminated | Phase 2 | Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer | June 2012 | May 21, 2015 |
| NCT02887365 | Unknown status | Phase 4 | A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer | September 2014 | August 2017 |
| NCT03958435 | Unknown status | Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery | November 9, 2018 | December 15, 2023 | |
| NCT02448173 | Unknown status | Phase 3 | A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer | May 2015 | July 2022 |